SCIENCE

Economy

Universal basic income could be coming for kids

Entrepreneurs, intellectuals and presidential candidates have in recent years touted “universal basic income,” a cash stipend to everyone with no strings attached, as the answer to poverty, automation and the drudgery of work. It has never gotten off the ground in the U.S.

Markets

Gilead to buy Immunomedics in $21B deal

Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the companies said on Sunday in a statement.